Covered recipient · General Payments record
CORY EDWARDS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$298.57
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.57 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $107.13 | 5 |
| Astellas Pharma US Inc | $55.59 | 3 |
| ABBVIE INC. | $41.22 | 2 |
| PFIZER INC. | $36.79 | 2 |
| Lilly USA, LLC | $25.12 | 1 |
| Corcept Therapeutics | $16.63 | 1 |
| Acerta Pharma LLC | $16.09 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $298.57 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.00 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103677539 | CMS |
| ABBVIE INC. | $19.22 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103677541 | CMS |
| Astellas Pharma US Inc | $18.63 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139284670 | CMS |
| Astellas Pharma US Inc | $21.67 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139334240 | CMS |
| Astellas Pharma US Inc | $15.29 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139433268 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.09 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104290472 | CMS |
| Corcept Therapeutics | $16.63 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117758903 | CMS |
| Lilly USA, LLC | $25.12 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136130098 | CMS |
| Novo Nordisk Inc | $21.26 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097527402 | CMS |
| Novo Nordisk Inc | $22.70 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096583738 | CMS |
| Novo Nordisk Inc | $20.20 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097475598 | CMS |
| Novo Nordisk Inc | $19.35 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096980585 | CMS |
| Novo Nordisk Inc | $23.62 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096890670 | CMS |
| PFIZER INC. | $13.31 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131922891 | CMS |
| PFIZER INC. | $23.48 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131939837 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.